story of the week
Neoantigen-Specific CD8 T Cell Responses in the Peripheral Blood Following PD-L1 Blockade Might Predict Outcomes in Metastatic Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Nat Commun 2022 Apr 11;13(1)1935, JS Holm, SA Funt, A Borch, KK Munk, AM Bjerregaard, JL Reading, C Maher, A Regazzi, P Wong, H Al-Ahmadie, G Iyer, T Tamhane, AK Bentzen, NO Herschend, S De Wolf, A Snyder, T Merghoub, JD Wolchok, M Nielsen, JE Rosenberg, DF Bajorin, SR HadrupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.